EFFICACY OF 5-AZACITIDINE IN THE TREATMENT OF HIGHER-RISK MYELODISPLASTIC SYNDROMES, ACUTE MYELOID LEUKEMIA AND CHRONIC MYELOMONOCYTIC LEUKEMIA: EXPERIENCE AT A SINGLE CENTER

被引：0
|
作者：
Vazquez, H. Hernandez [1 ]
Diez, E. Amutio [1 ]
Eizaguirre, I. Olazabal [1 ]
Malcorra, A. Balerdi [1 ]
Urkixo, I. Etxeguren [1 ]
Iruin, A. Uresandi [1 ]
Pomposo, M. Puente [1 ]
Usategui, M. Duenas [1 ]
Mazon, J. Mateos [1 ]
Perez, A. Iglesias [1 ]
Quintana, A. Moreto [1 ]
Frances, M. A. Pinan [1 ]
Goni, F. Floristan [1 ]
Martinez, M. C. Alvarez [1 ]
Ontoria, I. Hernandez [1 ]
Garcia-Ruiz, J. C. [1 ]
机构：
[1] Hosp Cruces, Baracaldo, Spain
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1405
引用
收藏
页码：564 / 565
页数：2
相关论文
共 50 条
  • [41] Real-World Costs of Azacitidine Treatment in Patients With Higher-Risk Myelodysplastic Syndromes/Low Blast-Count Acute Myeloid Leukemia
    Mozessohn, Lee
    Cheung, Matthew C.
    Mittmann, Nicole
    Earle, Craig C.
    Liu, Ning
    Buckstein, Rena
    JCO ONCOLOGY PRACTICE, 2021, 17 (04) : E517 - E525
  • [42] Azacitidine Alone Or The Combination With Valproic Acid As a Bridge Therapy For Acute Myeloid Leukemia and Higher-Risk Myelodysplastic Syndromes Before Transplantation
    Cabrera, Cristina Calderon
    Falantes, Jose F.
    Gomez, Marina
    Parody, Rocio
    Malaver, Francisco J. Marquez
    Martino, Marla L.
    Gonzalez, Jose
    Montero, Isabel
    Espigado, Ildefonso
    Perez-Simon, Jose Antonio
    BLOOD, 2013, 122 (21)
  • [43] Venetoclax and azacitidine in untreated patients with therapy-related acute myeloid leukemia, antecedent myelodysplastic syndromes or chronic myelomonocytic leukemia
    Vinod Pullarkat
    Keith W. Pratz
    Hartmut Döhner
    Christian Recher
    Michael J. Thirman
    Courtney D. DiNardo
    Pierre Fenaux
    Andre C. Schuh
    Andrew H. Wei
    Arnaud Pigneux
    Jun-Ho Jang
    Gunnar Juliusson
    Yasushi Miyazaki
    Dominik Selleslag
    Martha L. Arellano
    Chenglong Liu
    Jean A. Ridgeway
    Jalaja Potluri
    Jovita Schuler
    Marina Konopleva
    Blood Cancer Journal, 15 (1)
  • [44] A phase 1b study of glasdegib + azacitidine in patients with untreated acute myeloid leukemia and higher-risk myelodysplastic syndromes
    Mikkael A. Sekeres
    Michael Schuster
    Magalie Joris
    Jürgen Krauter
    Johan Maertens
    Dimitri Breems
    Emmanuel Gyan
    Tibor Kovacsovics
    Amit Verma
    Paresh Vyas
    Eunice S. Wang
    Keith Ching
    Thomas O’Brien
    Corrado Gallo Stampino
    Weidong Wendy Ma
    Arthur Kudla
    Geoffrey Chan
    Amer M. Zeidan
    Annals of Hematology, 2022, 101 : 1689 - 1701
  • [45] Real Life Data on Efficacy and Safety of Azacitidine Therapy for Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia
    Helbig, Grzegorz
    Chromik, Karolina
    Wozniczka, Krzysztof
    Kopinska, Anna J.
    Boral, Kinga
    Dworaczek, Martyna
    Koclega, Anna
    Armatys, Anna
    Panz-Klapuch, Marta
    Markiewicz, Miroslaw
    PATHOLOGY & ONCOLOGY RESEARCH, 2019, 25 (03) : 1175 - 1180
  • [46] Treatment Of Acute Non-Lymphocytic Leukemia With 5-Azacitidine
    Pasquale, Donald
    Thalody, Vimala
    Kim, Eugene
    Brodzik, Frank
    Mehdi, Syed A.
    BLOOD, 2013, 122 (21)
  • [47] Clinical impact of transformation to acute myeloid leukemia in patients with higher-risk myelodysplastic syndromes
    Kota, Vamsi
    Ogbonnaya, Augustina
    Farrelly, Eileen
    Schroader, Bridgette Kanz
    Raju, Aditya
    Kristo, Fjoralba
    Dalal, Mehul
    FUTURE ONCOLOGY, 2022, 18 (36) : 4017 - 4029
  • [48] A phase II study of the efficacy, safety, and determinants of response to 5-azacitidine (Vidaza®) in patients with chronic myelomonocytic leukemia
    Tantravahi, Srinivas K.
    Szankasi, Philippe
    Khorashad, Jamshid S.
    Dao, Kim-Hien
    Kovacsovics, Tibor
    Kelley, Todd W.
    Deininger, Michael W.
    LEUKEMIA & LYMPHOMA, 2016, 57 (10) : 2441 - 2444
  • [49] AZACITIDINE FOR TREATMENT OF MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID LEUKEMIAS: A SINGLE CENTER EXPERIENCE
    Michallet, M.
    Champigneulle, C.
    Sobh, M.
    Morisset, S.
    Detrait, M.
    Nicolini, F.
    Labussiere, H.
    Ducastelle, S.
    Barraco, F.
    Chelghoum, Y.
    Thomas, X.
    Wattel, E.
    Ranchon, F.
    Rioufol, C.
    HAEMATOLOGICA, 2012, 97 : 275 - 276
  • [50] Systematic Literature Review of Treatment Options and Clinical Outcomes for Patients With Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia
    Bell, Jill A.
    Galaznik, Aaron
    Huelin, Rachel
    Stokes, Michael
    Guo, Yelan
    Fram, Robert J.
    Faller, Douglas V.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (04): : E157 - E166
12345